ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01FA09 | B | Clarithromycin - 250mg/5ml | 9582 | 46317/1 | KLACID | 250mg/5ml | 100ml | Granules for suspension | Oral | Mersaco | Abbvie SRL | Italy | 1,698,617 L.L | 23.08 | B | Abbott Laboratories Ltd | UK | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01FA09 | G | Clarithromycin - 250mg/5ml | 6047 | 167087/10 | CLARIDAR DAR AL DAWA | 250mg/5ml | 100ml | Suspension | Oral | Sadco | Dar Al Dawa | Jordan | 877,529 L.L | 23.08 | A2 | Dar Al Dawa | Jordan | 12/12/20 | 0 |